Organism: Homo sapiens
Gene: 38746_at
Selected probe(set): 204990_s_at
Platform: Affymetrix Human Genome U133 Plus 2.0 Array

Expression of 38746_at (204990_s_at) across 6674 perturbations tested by GENEVESTIGATOR:

Relative Expression (log2-ratio):4.719407
Number of Samples:2 / 9

Experimental	expO skin cancer study 1 (squamous cell carcinoma, NOS; metastatic)
	Metastatic tumor tissue samples obtained from patients with primary squamous cell carcinoma (NOS) of the skin.
Control	expO skin cancer study 1 (malignant melanoma, NOS; metastatic)
	Metastatic tumor tissue samples obtained from patients with primary malignant melanoma (NOS) of the skin.

Relative Expression (log2-ratio):-3.6809006
Number of Samples:22 / 46

Experimental	brain tumor study 1 (medulloblastoma)
	Primary tumor tissue sample from the brain of patients with medulloblastoma.
Control	brain tumor study 1 (ependymoma)
	Primary tumor tissue sample from the brain of patients with ependymoma.

Relative Expression (log2-ratio):-3.5466986
Number of Samples:6 / 3

Experimental	TNF-ɑ; TGF-ß2 study 1 (intermediate)
	ARPE-19 retina pigment epithelial cell samples treated with TNF-ɑ (10 ng/ml) and TGF-ß2 (5 ng/ml). Samples were taken 16 and 24 hours after treatment.
Control	untreated ARPE-19 cell sample
	Untreated ARPE-19 retina pigment epithelial cell samples harvested before adding TNF-ɑ (10 ng/ml) and TGF-ß2 (5 ng/ml).

Relative Expression (log2-ratio):3.456606
Number of Samples:11 / 6

Experimental	ovarian tumor study 11 (low grade)
	Human microdissected tumor cells from the ovary of patients with low grade serous carcinoma.
Control	normal ovarian surface epithelial cell sample
	Human microdissected ovarian surface epithelial cell sample from the ovary of healthy individuals.

Relative Expression (log2-ratio):3.3483772
Number of Samples:2 / 2

Experimental	collecting duct carcinoma study 1
	Tumor tissue samples from the kidney of patients with collecting duct carcinoma (CDC).
Control	normal kidney tissue (fetal)
	Normal fetal kidney tissue samples.

Relative Expression (log2-ratio):-3.272954
Number of Samples:6 / 3

Experimental	TNF-ɑ; TGF-ß2 study 1 (late)
	ARPE-19 retina pigment epithelial cell samples treated with TNF-ɑ (10 ng/ml) and TGF-ß2 (5 ng/ml). Samples were taken 42 and 60 hours after treatment.
Control	untreated ARPE-19 cell sample
	Untreated ARPE-19 retina pigment epithelial cell samples harvested before adding TNF-ɑ (10 ng/ml) and TGF-ß2 (5 ng/ml).

Relative Expression (log2-ratio):-3.243453
Number of Samples:19 / 4

Experimental	Merkel cell carcinoma study 3 (primary)
	Primary tumor tissue from the skin of patients with Merkel cell carcinoma.
Control	skin squamous cell carcinoma study 6
	Primary tumor tissue from the skin of patients with squamous cell carcinoma (SCC).

Relative Expression (log2-ratio):-3.0870485
Number of Samples:40 / 4

Experimental	melanoma study 34 (metastatic)
	Metastatic tumor tissue sample obtained from the patients with metastatic malignant melanoma of the skin. Metastatic samples composed of 22 macroscopic lymph node metastases, 16 subcutaneous metastases and 2 solid organ metastases (adrenal and brain).
Control	normal skin tissue
	Normal skin tissue.

Relative Expression (log2-ratio):3.069337
Number of Samples:43 / 4

Experimental	lung cancer study 1 (PDX; squamous cell carcinoma, NOS; primary)
	Patient-derived xenograft (PDX) samples generated in female athymic nude mice from patients with primary squamous cell carcinoma, NOS of the lung (subcutaneously implanted).
Control	lung cancer study 1 (PDX; large cell carcinoma, NOS; primary)
	Patient-derived xenograft (PDX) samples generated in female athymic nude mice from patients with primary large cell carcinoma, NOS of the lung (subcutaneously implanted).

Relative Expression (log2-ratio):-3.0471992
Number of Samples:2 / 2

Experimental	ovarian tumor study 30 (PDX; carcinoma, NOS; metastatic)
	Patient-derived xenograft (PDX) samples generated in female athymic nude mice from a metastasis of patients with primary carcinoma, NOS of the ovary (subcutaneously implanted). Metastatic site of patient tumor sample is not reported.
Control	ovarian tumor study 30 (PDX; adenocarcinoma, NOS; primary)
	Patient-derived xenograft (PDX) samples generated in female athymic nude mice from patients with primary adenocarcinoma, NOS of the ovary (subcutaneously implanted).